Abdelhamid Benazzouz was born in 1961 in Morocco. After completing an M.S. degree in the University of Tetouan (Morocco), he went to Bordeaux to prepare his Ph.D. degree in the field of neuroscience and pharmacology that he obtained in 1993. During his Ph.D. studies, he investigated a new therapeutical approach consisting of high-frequency stimulation of the subthalamic nucleus in a nonhuman primate model of Parkinson’s disease (PD). Then, in 1993, he joined the lab of Professor Alim-Louis Benabid in Grenoble to participate in transferring this approach to PD patients. In parallel with his hospital activity as a Neurophysiologist, he worked as the Head of a research group in the INSERM U.318 Unit. In 1998, he was appointed an INSERM position as a Permanent Researcher. In 2001, he joined the CNRS Unit of Professor Bernard Bioulac in Bordeaux. Furthermore, in 2005, he was promoted to Research Director position. Actually, Benazzouz serves as the Head of the Monoamines, DBS, and PD group. He has published more than 80 papers on peer-reviewed journals. Recently, he obtained the National Academy of Medicine Award (2003) and the Academy of Science Award (2007).
Biography Updated on 2 May 2011